TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 77 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,277,442 | -1.2% | 2,210,323 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $39,749,537 | +117.0% | 2,199,753 | +51.0% | 0.00% | 0.0% |
| Q1 2023 | $18,317,760 | -6.8% | 1,457,260 | +8.6% | 0.00% | 0.0% |
| Q4 2022 | $19,662,856 | +2.7% | 1,341,259 | +19.9% | 0.00% | 0.0% |
| Q3 2022 | $19,152,000 | +29.2% | 1,118,761 | +10.2% | 0.00% | – |
| Q2 2022 | $14,829,000 | +100.4% | 1,015,633 | +130.8% | 0.00% | – |
| Q1 2022 | $7,400,000 | -26.7% | 439,958 | -2.0% | 0.00% | – |
| Q4 2021 | $10,101,000 | +6.1% | 448,958 | +1.7% | 0.00% | – |
| Q3 2021 | $9,519,000 | -25.1% | 441,620 | +0.7% | 0.00% | – |
| Q2 2021 | $12,703,000 | +16.0% | 438,356 | +29.0% | 0.00% | – |
| Q1 2021 | $10,952,000 | -17.8% | 339,797 | +5.4% | 0.00% | – |
| Q4 2020 | $13,326,000 | – | 322,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,779,158 | $32,149,385 | 4.73% |
| COWEN AND COMPANY, LLC | 1,999,383 | $36,128,850 | 3.00% |
| Vivo Capital, LLC | 2,262,200 | $40,877,954 | 2.82% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $32,300,613 | 1.93% |
| Cormorant Asset Management, LP | 1,421,422 | $25,685,096 | 1.44% |
| Sands Capital Ventures, LLC | 260,000 | $4,698,200 | 1.39% |
| Ghost Tree Capital, LLC | 150,000 | $2,710,500 | 0.90% |
| RTW INVESTMENTS, LP | 2,548,125 | $46,044,619 | 0.88% |
| Perceptive Advisors | 1,296,416 | $23,426,237 | 0.68% |
| TFG Asset Management GP Ltd | 165,000 | $2,981,550 | 0.40% |